Stammdaten
Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also offers GeneStrat ddPCR and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions; and GeneStrat NGS (NGS) test, a 72-hour blood-based NGS test. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. Biodesix, Inc. was incorporated in 2005 and is headquartered in Boulder, Colorado.
Unternehmen & Branche
| Name | BIODESIX INC |
|---|---|
| Ticker | BDSX |
| CIK | 0001439725 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Medical - Diagnostics & Research |
| SIC | 8071 · Services-Medical Laboratories |
Wertpapier & Kennzahlen
| CUSIP | 09075X108 |
|---|---|
| ISIN | US09075X1081 |
| Typ | Common Stock |
| Marktkapitalisierung | 76,4 Mio. USD |
| Beta | 0,57 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-12-31 | 10-K | 88,499,000 | -35,265,000 | -4.67 | 87,476,000 | -2,465,000 |
| 2025-09-30 | 10-Q | 21,768,000 | -8,716,000 | -1.16 | 88,722,000 | -1,722,000 |
| 2025-06-30 | 10-Q | 20,018,000 | -11,468,000 | -0.08 | 87,740,000 | 1,138,000 |
| 2025-03-31 | 10-Q | 17,958,000 | -11,101,000 | -0.08 | 86,241,000 | 11,060,000 |
| 2024-12-31 | 10-K | 71,323,000 | -42,931,000 | -6.64 | 97,244,000 | 20,876,000 |
| 2024-09-30 | 10-Q | 18,151,000 | -10,258,000 | -1.40 | 102,743,000 | 27,857,000 |
| 2024-06-30 | 10-Q | 17,925,000 | -10,808,000 | -0.08 | 115,841,000 | 36,260,000 |
| 2024-03-31 | 10-Q | 14,818,000 | -13,614,000 | -0.14 | 87,201,000 | -5,502,000 |
| 2023-12-31 | 10-K | 49,087,000 | -52,146,000 | -0.64 | 99,096,000 | 4,580,000 |
| 2023-09-30 | 10-Q | 13,491,000 | -10,949,000 | -0.14 | 86,786,000 | -1,446,000 |
| 2023-06-30 | 10-Q | 11,872,000 | -13,356,000 | -0.17 | 77,623,000 | -6,993,000 |
| 2023-03-31 | 10-Q | 9,056,000 | -18,702,000 | -0.24 | 80,793,000 | 4,550,000 |
| 2022-12-31 | 10-K | 38,212,000 | -65,447,000 | -1.55 | 92,906,000 | 20,606,000 |
| 2022-09-30 | 10-Q | 11,107,000 | -13,699,000 | -0.34 | 63,198,000 | -2,903,000 |
| 2022-06-30 | 10-Q | 10,950,000 | -15,824,000 | -0.40 | 75,229,000 | 7,671,000 |
| 2022-03-31 | 10-Q | 6,548,000 | -15,586,000 | -0.50 | 61,651,000 | 7,781,000 |
| 2021-12-31 | 10-K | 54,506,000 | -43,159,000 | -1.58 | 76,097,000 | 19,727,000 |
| 2021-09-30 | 10-Q | 6,531,000 | -11,514,000 | -0.41 | 89,997,000 | 16,033,000 |
| 2021-06-30 | 10-Q | 11,885,000 | -11,402,000 | 101,804,000 | 25,773,000 | |
| 2021-03-31 | 10-Q | 28,866,000 | -6,961,000 | 115,486,000 | 36,432,000 |
Fondsaktivität (Vorquartalsvergleich)
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| Birchview Capital, LP | 286,804 | 0 | 286,804 | 1,950,267 | Neu | +100,0% | |
| Aberdeen Group plc | 262,425 | 0 | 262,425 | 1,784,490 | Neu | +100,0% | |
| VANGUARD GROUP INC | 192,138 | 0 | 192,138 | 1,306,538 | Neu | +100,0% | |
| PERCEPTIVE ADVISORS LLC | 108,694 | 0 | 108,694 | 739,119 | Neu | +100,0% | |
| PERKINS CAPITAL MANAGEMENT INC | 44,783 | 0 | 44,783 | 304,524 | Neu | +100,0% | |
| GEODE CAPITAL MANAGEMENT, LLC | 42,453 | 0 | 42,453 | 288,753 | Neu | +100,0% | |
| Trexquant Investment LP | 27,542 | 0 | 27,542 | 187,286 | Neu | +100,0% | |
| CITADEL ADVISORS LLC | 25,985 | 0 | 25,985 | 176,698 | Neu | +100,0% | |
| BlackRock, Inc. | 24,466 | 0 | 24,466 | 166,369 | Neu | +100,0% | |
| STATE STREET CORP | 17,802 | 0 | 17,802 | 121,054 | Neu | +100,0% | |
| Shay Capital LLC | 16,145 | 0 | 16,145 | 109,786 | Neu | +100,0% | |
| DRW Securities, LLC | 15,372 | 0 | 15,372 | 104,529 | Neu | +100,0% | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 12,500 | 0 | 12,500 | 85,000 | Neu | +100,0% | |
| NORTHERN TRUST CORP | 11,134 | 0 | 11,134 | 75,711 | Neu | +100,0% | |
| Cetera Investment Advisers | 10,000 | 0 | 10,000 | 68,000 | Neu | +100,0% | |
| Allworth Financial LP | 4,965 | 0 | 4,965 | 33,762 | Neu | +100,0% | |
| Tower Research Capital LLC (TRC) | 193 | 0 | 193 | 1,312 | Neu | +100,0% | |
| Fortitude Family Office, LLC | 171 | 0 | 171 | 1,163 | Neu | +100,0% | |
| BANK OF AMERICA CORP /DE/ | 143 | 0 | 143 | 972 | Neu | +100,0% | |
| GROUP ONE TRADING LLC | 100 | 0 | 100 | 680 | Neu | +100,0% | |
| GSA CAPITAL PARTNERS LLP | 64,483 | 0 | 64,483 | 438 | Neu | +100,0% | |
| MORGAN STANLEY | 61 | 0 | 61 | 415 | Neu | +100,0% | |
| FMR LLC | 1 | 0 | 1 | 7 | Neu | +100,0% |
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-01-26 | SCHULER JACK W | 10% Owner | Open Market Purchase | 20,000 | 11.80 | 236,064.00 | +35,3% | |
| 2026-01-23 | SCHULER JACK W | 10% Owner | Open Market Purchase | 80,000 | 11.81 | 944,672.00 | +141,4% | |
| 2026-01-22 | SCHULER JACK W | 10% Owner | Open Market Purchase | 82,465 | 10.96 | 903,560.76 | +135,3% | |
| 2025-09-19 | SCHULER JACK W | Director, 10% Owner | Open Market Purchase | 142,045 | 7.04 | 999,996.80 | +149,7% | |
| 2025-09-18 | SCHULER JACK W | Director, 10% Owner | Open Market Purchase | 3,056 | 6.17 | 18,853.99 | +2,8% | |
| 2025-09-17 | SCHULER JACK W | Director, 10% Owner | Open Market Purchase | 15,317 | 6.04 | 92,571.35 | +13,9% | |
| 2025-08-29 | SCHULER JACK W | Director, 10% Owner | Open Market Purchase | 3,488,372 | 0.43 | 1,499,999.96 | +224,5% | |
| 2025-05-19 | SCHULER JACK W | Director, 10% Owner | Open Market Purchase | 723,239 | 0.34 | 246,624.50 | +36,9% | |
| 2025-05-16 | SCHULER JACK W | Director, 10% Owner | Open Market Purchase | 4,000,000 | 0.27 | 1,070,000.00 | +160,2% |
Top-Fondshalter
Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 31.12.2025. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.
| Fonds | Anteile | Wert (USD) | Anteil (%) |
|---|---|---|---|
| Birchview Capital, LP | 286,804 | 1,950,267 | 25.98 |
| Aberdeen Group plc | 262,425 | 1,784,490 | 23.77 |
| VANGUARD GROUP INC | 192,138 | 1,306,538 | 17.40 |
| PERCEPTIVE ADVISORS LLC | 108,694 | 739,119 | 9.85 |
| PERKINS CAPITAL MANAGEMENT INC | 44,783 | 304,524 | 4.06 |
| GEODE CAPITAL MANAGEMENT, LLC | 42,453 | 288,753 | 3.85 |
| Trexquant Investment LP | 27,542 | 187,286 | 2.49 |
| CITADEL ADVISORS LLC | 25,985 | 176,698 | 2.35 |
| BlackRock, Inc. | 24,466 | 166,369 | 2.22 |
| STATE STREET CORP | 17,802 | 121,054 | 1.61 |
| Shay Capital LLC | 16,145 | 109,786 | 1.46 |
| DRW Securities, LLC | 15,372 | 104,529 | 1.39 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 12,500 | 85,000 | 1.13 |
| NORTHERN TRUST CORP | 11,134 | 75,711 | 1.01 |
| Cetera Investment Advisers | 10,000 | 68,000 | 0.91 |
| Allworth Financial LP | 4,965 | 33,762 | 0.45 |
| Tower Research Capital LLC (TRC) | 193 | 1,312 | 0.02 |
| Fortitude Family Office, LLC | 171 | 1,163 | 0.02 |
| BANK OF AMERICA CORP /DE/ | 143 | 972 | 0.01 |
| GROUP ONE TRADING LLC | 100 | 680 | 0.01 |